UBS Group’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-226,458
Closed -$40.7M 8436
2017
Q3
$40.7M Buy
226,458
+170,614
+306% +$23.8M 0.02% 705
2017
Q2
$5.79M Buy
55,844
+25,964
+87% +$2.12M ﹤0.01% 2014
2017
Q1
$2.35M Sell
29,880
-76,519
-72% -$4.73M ﹤0.01% 2802
2016
Q4
$4.77M Buy
106,399
+64,737
+155% +$3.18M ﹤0.01% 2136
2016
Q3
$2.33M Sell
41,662
-87,509
-68% -$4.88M ﹤0.01% 2708
2016
Q2
$6.46M Buy
129,171
+87,871
+213% +$4.32M 0.01% 1731
2016
Q1
$1.9M Sell
41,300
-147,432
-78% -$7.14M ﹤0.01% 2719
2015
Q4
$11.6M Buy
188,732
+76,734
+69% +$5.4M 0.01% 1297
2015
Q3
$6.24M Buy
111,998
+40,102
+56% +$2.52M 0.01% 1733
2015
Q2
$4.38M Buy
71,896
+5,942
+9% +$339K ﹤0.01% 2210
2015
Q1
$3.8M Buy
65,954
+49,861
+310% +$3.34M ﹤0.01% 2313
2014
Q4
$928K Buy
+16,093
New +$678K ﹤0.01% 3631